ARTEMIS

Welcome to the Brand page for “ARTEMIS”, which is offered here for Biologics, chimeric immune cell antigen receptors, engineered immune cells made from an individual patient's immune cells and proprietary dna, for therapeutic use for the treatment of cancers, for the treatment of proliferative cell diseases, and in transplantation;.

Its status is currently believed to be active. Its class is unavailable. “ARTEMIS” is believed to be currently owned by “EUREKA THERAPEUTICS, INC.”

Owner:
EUREKA THERAPEUTICS, INC.
Owner Details
Description:
Biologics, chimeric immune cell antigen receptors, engineered immune cells made from an individual patient's immune cells and proprietary DNA, for therapeutic use for the treatment of cancers, for the treatment of proliferative cell diseases, and in transplantation;
Categories: BIOLOGICS